ArticleDiabetology international2026

Discontinuation of oral semaglutide due to adverse effects: a database study on Japanese individuals with type 2 diabetes.

Mizuki Ishiguro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.